Dynamic Drug Advancement Limited | Durham Institute of Respirology
COPD Clinical Research Studies
Breztri NGP
Assessing a new generation, environmentally friendly propellant known as HFO (hydrofluoroolefin) in the Breztri inhaler. This study is for patients with Moderate to Very Severe
AERIFY
Utilization of Itepekimab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Mechanism: Anti-IL-33
ARNASA
Utilization of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease With a History of Exacerbations
Mechanism: Anti-IL-33
NOTUS
Utilization of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation.
Mechanism: Anti-Il-4
RESOLUTE
Utilization of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations
Mechanism: Anti-IL-5
MATINEE
Utilization of Mepolizumab as Add-on Treatment In Patients With COPD Characterized by Frequent Exacerbations and Eosinophil Level
Mechanism: Anti-IL-5
OBERON
Utilization of Tozorakimab in Patients with Chronic Obstructive Pulmonary Disease With a History of Exacerbations
Mechanism: Anti-IL-33
Asthma Clinical Research Studies
NIMBLE
Utilization of Depemokimab Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
Mechanism: Anti-IL-5
KALOS
Utilization of Budesonide, Glycopyrronium, and Formoterol Fumarate metered dose inhaler relative to Budesonide and Formoterol Fumarate MDI and Symbicort® pressurized MDI in patients with inadequately controlled asthma
ATLAS
Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma
Mechanism: Anti-IL-4
VATHOS
Utilization of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler and Open-Label Symbicort® Turbuhaler® in Adult and Adolescent Patients With Inadequately Controlled Asthma
CONTACT US
SUNRISE
Utilizing Tezepelumab in Adult Patients With Oral Corticosteroid Dependent Asthma
Mechanism: Anti-TSLP
LITHOS
Utilization of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Adult and Adolescent Patients With Inadequately Controlled Asthma
CONTACT US
Chronic Cough Clinical Research Studies
CALM
Utilizing BLU-5937 in Adult Participants with Refractory Chronic Cough, Including Unexplained Chronic Cough
Mechanism: P2X3 receptor antagonist
Idiopathic Pulmonary Fibrosis Clinical Research Studies
HARBOUR
Utilizing HZN-825 in Subjects with Idiopathic Pulmonary Fibrosis
Mechanism: LPAR1-specific Antagonist